ICD-10 Coding for Hepatocellular Cancer(B18.0, B18.1U, B18.2)
Learn about the ICD-10 coding for hepatocellular cancer, including code C22.0, documentation requirements, and common coding pitfalls.
Complete code families applicable to Hepatocellular Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C22.0 | Liver cell carcinoma | Use when there is a confirmed diagnosis of hepatocellular carcinoma. |
|
| T86.49 | Complications of liver transplant | Use when HCC is a complication of a liver transplant. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHepatocellular Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Hepatocellular Cancer.
Using unspecified liver cancer code
Impact
Clinical: Leads to vague clinical records., Regulatory: Non-compliance with specificity requirements., Financial: Potential for denied claims.
Mitigation
Use C22.0 for confirmed HCC., Document etiology and staging.
Incorrect sequencing of transplant-related HCC
Impact
Reimbursement: Incorrect sequencing can lead to improper DRG assignment., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Affects accuracy of patient records.
Mitigation
Sequence T86.49 before C22.0
Transplant-related HCC coding
Impact
Incorrect sequencing of codes can lead to audit flags.
Mitigation
Follow updated sequencing guidelines.